Correlation Between Gain Therapeutics and Aligos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Gain Therapeutics and Aligos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gain Therapeutics and Aligos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gain Therapeutics and Aligos Therapeutics, you can compare the effects of market volatilities on Gain Therapeutics and Aligos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gain Therapeutics with a short position of Aligos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gain Therapeutics and Aligos Therapeutics.
Diversification Opportunities for Gain Therapeutics and Aligos Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Gain and Aligos is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Gain Therapeutics and Aligos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aligos Therapeutics and Gain Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gain Therapeutics are associated (or correlated) with Aligos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aligos Therapeutics has no effect on the direction of Gain Therapeutics i.e., Gain Therapeutics and Aligos Therapeutics go up and down completely randomly.
Pair Corralation between Gain Therapeutics and Aligos Therapeutics
Given the investment horizon of 90 days Gain Therapeutics is expected to under-perform the Aligos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Gain Therapeutics is 1.23 times less risky than Aligos Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Aligos Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 2,230 in Aligos Therapeutics on November 28, 2024 and sell it today you would lose (462.00) from holding Aligos Therapeutics or give up 20.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gain Therapeutics vs. Aligos Therapeutics
Performance |
| Timeline |
| Gain Therapeutics |
| Aligos Therapeutics |
Gain Therapeutics and Aligos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gain Therapeutics and Aligos Therapeutics
The main advantage of trading using opposite Gain Therapeutics and Aligos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gain Therapeutics position performs unexpectedly, Aligos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aligos Therapeutics will offset losses from the drop in Aligos Therapeutics' long position.| Gain Therapeutics vs. Beam Therapeutics | Gain Therapeutics vs. Editas Medicine | Gain Therapeutics vs. Caribou Biosciences | Gain Therapeutics vs. Verve Therapeutics |
| Aligos Therapeutics vs. CytomX Therapeutics | Aligos Therapeutics vs. Spero Therapeutics | Aligos Therapeutics vs. Instil Bio | Aligos Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |